Patients with complete MPO-deficiencies are prone to recurrent mucosal fungal infections, but their immune deficiency is milder than chronic granulomatous disease (CGD) which is associated with mutations that disrupt the production of the upstream oxidant superoxide by the NADPH oxidase Nox2. Here, FMO5 is linked to chronic granulomatous disease.